Growth Metrics

Nu-Med Plus (NUMD) Cash from Investing Activities (2012 - 2022)

Nu-Med Plus recorded quarterly Cash from Investing Activities of $3000.0 in Q1 2022, up 299900.0% quarter-over-quarter from $1.0 in Q4 2018.

Nu-Med Plus' Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $3000.0 for Q1 2022.

  • In Q1 2022, Cash from Investing Activities changed N/A year-over-year to $3000.0; the TTM figure through Sep 2022 stood at $3000.0 (changed N/A YoY), while the FY2018 annual figure was -$5025.0, changed N/A from the prior year.
  • Cash from Investing Activities came in at $3000.0 for Q1 2022 at Nu-Med Plus, up from $1.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $3000.0 in Q1 2022 to a low of -$5026.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.32 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -185.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.50 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -217.20 Mn
10 Nu-Med Plus - - - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 3,000.00
Mar 31, 2022 3,000.00
Dec 31, 2018 1.00
Dec 31, 2018 1.00
Jun 30, 2018 -5,026.00
Jun 30, 2018 -5,026.00
Dec 31, 2014 -1,101.00
Dec 31, 2014 -1,101.00
Sep 30, 2013 -1,679.00
Sep 30, 2013 -1,679.00
Dec 31, 2012 -19,354.00
Dec 31, 2012 -19,354.00
Sep 30, 2012 -1.00
Sep 30, 2012 -1.00
Jun 30, 2012 -18,835.00
Jun 30, 2012 -18,835.00